Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The physical filtration barrier refers to specialized multi-layered structures, such as the glomerular filtration barrier (GFB) or the blood-brain barrier (BBB), that regulate the selective passage of substances between physiological compartments (Pollak et al., 2014, PMID: 25135271). In the kidney, the GFB consists of the fenestrated endothelium, the glomerular basement membrane, and podocytes, which collectively prevent the loss of essential proteins like albumin into the urine (Haraldsson et al., 2008, PMID: 18337451). This selective permeability is crucial for maintaining systemic homeostasis and protecting sensitive tissues from toxins or pathogens. Dysfunction of these barriers is central to the pathogenesis of diseases such as nephrotic syndrome, where barrier breakdown leads to massive proteinuria, or neuroinflammatory conditions where BBB permeability increases (Daneman & Prat, 2015, PMID: 25560979). While the barrier is a structural entity rather than a single protein, it is a major focus of therapeutic strategies aimed at preserving integrity or modulating permeability. For instance, ACE inhibitors and ARBs are used to reduce intraglomerular pressure and protect the GFB in diabetic nephropathy (Lewis et al., 1993, PMID: 8413402). Additionally, osmotic agents like mannitol are employed to temporarily disrupt the BBB for the delivery of chemotherapeutic agents to the central nervous system (StatPearls, 2023).
Reduction of hydrostatic pressure, stabilization of structural proteins, or osmotic modulation of tight junctions.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physical Filtration Barrier.